alexa The Curious Path of Pharmacovigilance

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The Curious Path of Pharmacovigilance

Most advances in technology come from a traditional pathway of basic research performed in university laboratories or in governmental institutions. That is generally followed by commercial laboratories in the private sector taking over the basic science research and conducting applied research to make the goods or services of value to the individual or organizational consumer. Such private sector Research and Development (R and D) is often a lot more Development than research. After a new potential drug product active ingredient is synthesized in a university laboratory, the industry takes over in determining the correct adult dosage, and develops a formulation that is optimal for the typical patient. Then the pharmaceutical firm conducts the required clinical trials, the registration submission, arranges for manufacture, staff training, physician education and overall marketing, promotion and sales.


Citation: Wertheimer AI (2013) The Curious Path of Pharmacovigilance. J Pharmacovigilance 1:e109. doi: 10.4172/2329-6887.1000e109

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger